Several studies have also reported increased sensitivity of human liver, lung, colorectal, cervical, nasopharyngeal and osteosarcoma cancer cells to therapeutic drugs when treated with OAs expressing IL-24 [39,40,41]. The gene discussed is IL24; the disease is cancer.